Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
7 holders
Ownership
Activity
Fundamentals
2016 Q1
40 of 52 quarters
Total Value
$546.95M
Total Shares
5.95M
Net Share Change
+739.6K
Activity
6 buying
1 selling
Investor
Value
Shares
Weight
Change
Egerton Capital
$415.36M
4.52M
4.0%
ADD
+230.2K
(+5.4%)
Egerton Capital
$415.36M
4.52M shares
ADD
+230.2K
(+5.4%)
Miller Value Partners
$48.10M
523.7K
1.9%
TRIM
-53.9K
(-9.3%)
Miller Value Partners
$48.10M
523.7K shares
TRIM
-53.9K
(-9.3%)
Leon Cooperman
$47.49M
517.0K
1.3%
NEW
Leon Cooperman
$47.49M
517.0K shares
NEW
Bridgewater Associates LP
$22.95M
249.8K
0.3%
ADD
+31.7K
(+14.5%)
Bridgewater Associates LP
$22.95M
249.8K shares
ADD
+31.7K
(+14.5%)
Matrix Asset Advisors
$12.12M
131.9K
2.4%
ADD
+10.6K
(+8.8%)
Matrix Asset Advisors
$12.12M
131.9K shares
ADD
+10.6K
(+8.8%)
Maverick Capital
$517.0K
5.6K
0.0%
ADD
+3.3K
(+140.6%)
Maverick Capital
$517.0K
5.6K shares
ADD
+3.3K
(+140.6%)
Jensen Investment Management
$407.0K
4.4K
0.0%
ADD
+660
(+17.5%)
Jensen Investment Management
$407.0K
4.4K shares
ADD
+660
(+17.5%)
GILD — Gilead Sciences, Inc. - FilingSpy